Immunogenicity and immune tolerance coagulation Factors VIII and IX
Affiliations
- PMID: 12762504
Item in Clipboard
Immunogenicity and immune tolerance coagulation Factors VIII and IX
Dev Biol (Basel).
2003.
Abstract
Some of the major issues related to the development and control of antibodies that occur during treatment of haemophilia with replacement factors (Factor VIII and Factor IX) are reviewed. Information on analytical issues, immunogenicity, and immune tolerance may be applicable to the study of other therapeutic proteins. Conversely, new information obtained from evaluation of other therapeutic protein products may address issues that remain unresolved for Factor VIII and FIX replacement therapy.
Similar articles
-
Immunological aspects of inhibitor development.Haemophilia. 2006 Dec;12 Suppl 6:30-5; discussion 35-6. doi: 10.1111/j.1365-2516.2006.01363.x. Haemophilia. 2006. PMID: 17123391 Review.
-
Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.Thromb Haemost. 1999 Aug;82(2):531-9. Thromb Haemost. 1999. PMID: 10605747 Review. No abstract available.
-
Inhibitors in young boys with haemophilia.Baillieres Best Pract Res Clin Haematol. 2000 Sep;13(3):457-68. doi: 10.1053/beha.2000.0088. Baillieres Best Pract Res Clin Haematol. 2000. PMID: 11030045 Review.
-
Induction of immune tolerance in hemophiliacs with inhibitors by combined treatment with i.v. IgG, cyclophosphamide and factor VIII or IX.Prog Clin Biol Res. 1990;324:69-78. Prog Clin Biol Res. 1990. PMID: 2106694 No abstract available.
-
Rituximab in the treatment of alloimmune factor VIII and IX antibodies in two children with severe haemophilia.Br J Haematol. 2004 May;125(3):366-8. doi: 10.1111/j.1365-2141.2004.04916.x. Br J Haematol. 2004. PMID: 15086418
Cited by
-
The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions.MAbs. 2010 May-Jun;2(3):256-65. doi: 10.4161/mabs.2.3.11641. Epub 2010 May 1. MAbs. 2010. PMID: 20400861 Free PMC article.